Cardio-oncology aims to identify cancer therapy-related cardiovascular side-effects and to provide optimum multidisciplinary care for cancer patients. We are in the process of gaining a profound knowledge on underlying pathomechanisms and clinical implications, but standardized recommendations and structural requirements for the treatment of cardio-oncology patients are still limited. In this edition of the Journal, experts in the field shield light on novel aspects and data for the diagnostic and therapy of cancer therapy—induced cardiovascular diseases. They critically review the literature and give recommendation for the daily practice.
